Listed diagnostic test manufacturer Abingdon Health has secured a $2m contract to support the development of sexually transmitted disease tests.
The York-headquartered company has entered into a contract with US-based Find Out From Home LLC (FOFH) regarding performance evaluation, regulatory services and clinical testing of four sexually transmitted disease (STD) tests.
The contract is worth a total of $2m and will be undertaken throughout 2025.
The FOFH contract is designed to allow the necessary regulatory processes to be completed to allow submission for approval by US FDA and UKCA and CE marking via IVDR. This will enable commercialisation of four lateral flow self-tests for HIV, hepatitis B, hepatitis C and syphilis in the USA, UK and EU.
Chris Yates, chief executive at Abingdon Health plc, said: “We are pleased to announce this contract win, which importantly utilises each limb of our business, including our development, scale-up, manufacturing, regulatory and analytical services, illustrating the breadth of expertise that Abingdon brings to its CDMO customer base.
“We have worked with FOFH to bring these STD products through technical transfer to this stage of commercialisation. This work brings further value to Abingdon Health via our 17 per cent shareholding in FOFH, which we previously announced through a service-for-equity arrangement.”
Alongside the contract win, Abingdon Health has also announced the opening of a new analytical laboratory at its Doncaster facilities. The laboratory will be operated by its wholly-owned subsidiary, Abingdon Analytical Ltd.
Dr Chris Hand, executive chairman of Abingdon Health, said: “This next step in our expansion provides a comprehensive analytical services laboratory, forming a bridge between our CDMO and regulatory service offerings, and linking our group companies, Abingdon Health, IVDeology and CS (Life Sciences).
“The capability to generate analytical and product performance data for use in a product’s regulatory technical file adds another element to the broad portfolio of services we offer our customers.
“The first major contract announced today illustrates the benefit of adding this analytical capability to our CDMO offering.”
For more information about Abingdon Health, visit their website: abingdonhealth.com